Bayer HealthCare / Animal Health

Animal Health

Picture: Pigs
  • Net sales in 2010: EUR 1,120 million
  • Headquarters: Monheim (Germany)

The goals of the Animal Health Division are to maintain the health of animals and cure veterinary diseases, with the focus primarily on treating infectious diseases and repelling parasites. In livestock – animals that play a role in food production – the safety of drug and care products is paramount for food safety. Companion animals receive special attention in clinical practice: in view of the emotional ties that people have to them but also their close relationship to the family, it is vital that they receive dependable, easy-to-use and safe medication in order to safeguard both their well-being and that of their owners.
With more than 100 different animal health and care products worldwide for livestock and companion animals, the division is one of the most successful suppliers in the field of veterinary medicine. Animal Health is well positioned in the steadily growing market for antiparasitic products for companion animals. The Advantage family of flea control products for dogs and cats was again one of Bayer HealthCare’s best-selling consumer health products in 2010, generating annual sales of roughly € 408 million. Baycox for the treatment of coccidiosis, a parasitic infectious disease in livestock, enjoyed double-digit sales growth relative to the previous year. The Baytril antibiotic for the treatment of serious infectious diseases in livestock and companion animals has been setting standards for many years.

Animal Health strengthened its business with acquisitions in 2010. The acquisition of the New Zealand-based Bomac Group added products for the treatment of mastitis and for parasite control in sheep to the farm animal product portfolio. Animal Health also ac-quired a technology from the U.S. company Piedmont Pharmaceuticals: a novel chewa-ble tablet formulation that makes it possible to administer active ingredients to dogs and cats easily and reliably.

With sales of € 1.1 billion in 2010, the Animal Health Division contributed 6.6 percent to Bayer HealthCare’s total sales. The main part of the division’s sales came from the Re-gion North America with 36.9 percent, followed by the Region Europe/Japan/MERA (Middle East, Eastern Europe, Russia and Africa) with 33.3 percent and the Region In-ternational (Asia Pacific, Latin America, South Africa) with 29.8 percent. Animal Health is active in more than 120 countries. Its animal health and care products are produced mainly in Germany and the United States, as well as at additional regional production sites.

The key products include

  • flea-control medications such as Advantage®, for dogs and cats,
  • products against ticks,
  • drugs to treat infectious diseases in livestock and companion animals (Baytril®),
  • products to control endoparasites in pets (Drontal® and Drontal® Plus)
  • as well as Baycox®, the innovative product to control coccidia problems in farm animals.


More information about our other Divisions

 
Search
Bayer HealthCare Links

Financial Report
Annual Report 2009
Company Brochure
Company Brochure

http://www.bayerhealthcare.com/scripts/pages/en/company/corporate_profile/divisions/animal_health/index.php

Copyright © Bayer HealthCare AG